The topical steroid contraindication in contact lens-related keratitis and herpes simplex keratitis is one of the most important prescribing safety principles in primary care ophthalmology. Topical corticosteroids suppress the immune response that is normally keeping infectious keratitis in check — in HSV keratitis (dendritic ulcer), steroids cause the characteristic branching ulcer to spread into a large geographic amoeboid ulcer with rapid corneal thinning and risk of perforation. In bacterial and Acanthamoeba keratitis (both common in contact lens wearers), steroids allow unchecked microbial proliferation and corneal melting. The clinical rule is: never prescribe topical steroids for a red eye without a slit-lamp examination confirming there is no corneal involvement. Topical ocular steroids should be ophthalmology-led; in general practice the safest rule is: never prescribe topical steroids for any red eye in a contact lens wearer, and never prescribe topical steroids for any unilateral red eye with photophobia or corneal cloudiness without ophthalmology review. Vernal keratoconjunctivitis (VKC) is a sight-threatening condition that is distinct from common allergic conjunctivitis and is frequently under-diagnosed and under-treated in primary care — it affects primarily boys under 14, is associated with atopy (asthma, eczema, hayfever), is more prevalent in South Asian and Middle Eastern children in the UK, and can cause permanent corneal scarring (shield ulcers) from the mechanical trauma of the giant papillae rubbing on the cornea during blinking. The examination finding of giant cobblestone papillae under the upper eyelid (requiring upper lid eversion — a skill GPs should have) is diagnostic. These children need ophthalmology referral and specialist topical immunomodulatory treatment, not just OTC antihistamine eye drops. Hutchinson's sign in herpes zoster ophthalmicus (vesicular rash on the tip of the nose) is a clinical sign that strongly predicts eye involvement — the nasociliary branch of V1 supplies both the tip of the nose and the eye. A rash on the tip of the nose increases the likelihood of ocular complications (keratitis, uveitis, scleritis), but absence of Hutchinson's sign does not exclude ocular involvement. Same-day ophthalmology is required for a V1 rash or Hutchinson's sign, or for eye pain, photophobia, visual symptoms, red eye or corneal involvement, following the local HZO pathway.

The distinction between itching (allergic/blepharitis/dry eye) and pain (infective/inflammatory) is the most important first clinical discriminator in eye presentations — itching is predominantly a feature of Type I hypersensitivity reactions (allergic conjunctivitis) and ocular surface disorders (dry eye, blepharitis), whereas pain, photophobia, and visual change are features of more serious pathology. However, this distinction is not absolute — patients with severe allergic conjunctivitis (especially VKC) can experience significant discomfort amounting to pain from the friction of giant papillae on the cornea, and patients with iritis can have some ocular discomfort described as "itching." The key principle is that any itchy eye with visual change, severe photophobia, or unilateral presentation should be examined carefully before attributing to simple allergy. Meibomian gland dysfunction (MGD) is one of the most important and most under-diagnosed causes of itchy eyes in adults — it causes posterior blepharitis through obstruction of the meibomian glands (which produce the oily outer layer of the tear film that prevents evaporation). When these glands are obstructed by abnormally viscous meibum (often keratinised), the tear film becomes lipid-deficient, evaporates rapidly, and the resulting dryness causes itch, burning, and grittiness. MGD is common in older adults. The treatment (warm compresses + lid massage to express blocked meibomian glands + lid cleaning) is largely primary care-managed. GPs should be aware that most patients who present with "itchy dry eyes" unresponsive to antihistamine drops have MGD and need lid hygiene rather than more antihistamine. Contact dermatoconjunctivitis from benzalkonium chloride (BAK) preservative is an important and very common cause of itchy eyes that paradoxically worsens with the eye drop treatment — BAK is the preservative in most multidose topical eye drops (including most antihistamine drops and artificial tears), and prolonged use can cause a toxic/allergic reaction, producing chronic itching, redness, and irritation that exactly mimics the condition the drops were prescribed to treat. If a patient's allergic eye symptoms worsen with eye drop treatment, switching to preservative-free formulations (single-dose units) will often produce dramatic improvement.

The papillae versus follicles distinction on the conjunctival surface is one of the most clinically useful examination findings in red/itchy eye assessment. Papillae are vascular mounds with a central capillary core, appearing as polygonal red dots — they indicate a cellular/allergic reaction and are seen in allergic conjunctivitis (small papillae <1 mm on inferior tarsal conjunctiva), VKC (giant papillae >1 mm on upper tarsal conjunctiva), and GPC. Follicles are avascular lymphoid aggregates appearing as translucent round bumps with vessels going around rather than through them — they indicate a lymphoid immune response and are seen in viral conjunctivitis (adenovirus — the most common cause of follicular conjunctivitis), chlamydial conjunctivitis (which must be excluded in any sexually active adult with chronic follicular conjunctivitis), and molluscum contagiosum affecting the eyelid margin. A GP who can reliably distinguish papillae from follicles using direct illumination and lid eversion can make the correct diagnosis in the majority of itchy/red eye cases. Upper lid eversion is a clinical skill that should be in every GP's repertoire — it provides the crucial examination of the upper tarsal conjunctiva that reveals VKC, GPC, and papillary/follicular patterns. The most common reason VKC is missed in general practice is that the upper lid is not everted, so the diagnostic giant papillae are never seen. The bilateral vs unilateral rule is highly sensitive — bilateral itchy eyes almost always have a benign systemic cause (allergy, dry eye), whereas unilateral itchy eyes require examination to exclude infective, inflammatory (uveitis), or structural causes. A unilateral allergic conjunctivitis does occur (unilateral allergen exposure — working with animals on one side, unilateral contact lens reaction) but is less common and should trigger a more thorough examination.

The chlamydial conjunctivitis swab in sexually active adults with chronic follicular conjunctivitis is a frequently missed investigation — Chlamydia trachomatis (serovars D–K) causes a chronic, unilateral or bilateral, follicular conjunctivitis in sexually active adults, typically presenting as a red itchy eye with follicles on the inferior tarsal conjunctiva and preauricular lymph node enlargement (also seen in adenoviral conjunctivitis, so not diagnostic). It is caused by autoinoculation from genital chlamydial infection. The diagnosis is missed because: (1) it does not produce the acute purulent discharge of bacterial conjunctivitis; (2) it does not respond to topical antibiotics (chlamydia requires systemic treatment); (3) GPs do not routinely take a sexual history in the context of an eye presentation. Any adult with chronic unilateral follicular conjunctivitis not responding to topical treatment warrants a sexual history and chlamydial PCR swab from the eye and genital sites. Treatment follows the BASHH chlamydia guideline via sexual health — doxycycline 100 mg BD first-line, with the course length for ocular infection set by the GUM team. Partner notification is required. The specific IgE blood test for allergy immunotherapy (AIT) planning is important to understand — AIT (subcutaneous or sublingual desensitisation) is the only treatment that modifies the underlying allergic disease rather than simply suppressing symptoms. NICE TA1045 (updated August 2026) recommends house dust mite SLIT (12 SQ-HDM, Acarizax) for moderate to severe house dust mite allergic rhinitis (age 5–65) persisting despite symptom-relieving medicine, and subcutaneous immunotherapy (SCIT) is effective for pollens. AIT requires confirmed specific IgE sensitisation before initiation — blood or skin prick testing is mandatory. GPs who identify patients with severe, refractory allergic conjunctivitis (particularly HDM-driven perennial disease) should refer to allergy/immunology for AIT consideration, as this can produce lasting symptom-free periods years after the course is completed.

The NHS Minor Eye Conditions Service (MECS) is available in most ICB areas in England — it allows community optometrists with enhanced training to assess and manage minor eye conditions (including conjunctivitis, dry eye, blepharitis, and minor trauma) on the same day or next day, either as a direct patient self-referral or via GP referral. For straightforward itchy eye presentations, MECS provides a faster, more appropriate pathway than A&E ophthalmology (where simple allergy conjunctivitis should not be presenting) or a GP appointment where a slit lamp is unavailable. GPs should know whether their area has a MECS service and direct appropriate patients there. The VKC referral urgency (same-day if photophobia or corneal involvement, otherwise within 1 week — not routine) reflects the sight-threatening potential of this condition — corneal shield ulcers from giant papillae-induced mechanical trauma can develop rapidly during peak seasonal exposure and require urgent specialist treatment. A child with severe seasonal itchy eyes who has been treated with OTC antihistamine drops for months without significant improvement, particularly a South Asian or Middle Eastern boy, should have their upper lids everted at GP examination. Finding giant papillae mandates urgent ophthalmology referral, not an escalation to prescription antihistamine drops. The allergy immunotherapy referral pathway for severe rhinoconjunctivitis is one of the most under-used referrals in primary care — sublingual immunotherapy (SLIT) with grass pollen or house dust mite allergen extracts can produce sustained benefit in seasonal allergic conjunctivitis and rhinitis, including reduced medication requirements that persist years after the treatment course ends. It is specialist-initiated, for adults with severe symptoms inadequately controlled by pharmacotherapy. The barrier is typically the multi-year commitment required (3–5 years of daily sublingual drops or monthly injections) and the availability of allergy clinic appointments — GPs who identify a patient with severe refractory allergic rhinoconjunctivitis should proactively refer to allergy/immunology rather than escalating pharmacotherapy indefinitely.

Olopatadine is one first-line topical option (choose per local formulary) for allergic conjunctivitis; it has a dual mechanism — it is both an H1 receptor antagonist AND a mast cell stabiliser, preventing both the immediate-phase reaction (histamine-mediated itch within minutes of allergen exposure) and the late-phase reaction (cytokine-mediated inflammation 4–8 hours later). This dual mechanism means it provides both immediate symptomatic relief and sustained prophylaxis with BD dosing, making it more effective and more convenient than antihistamines alone (which only block immediate-phase) or mast cell stabilisers alone (which only prevent late-phase when used prophylactically). The prescribing principle of pre-seasonal dosing for mast cell stabilisers (sodium cromoglicate, nedocromil) is important — these drugs do not provide immediate relief. They work by stabilising mast cell membranes, preventing degranulation on allergen contact. This prophylactic mechanism requires consistent use for 2–4 weeks before allergen exposure to achieve maximum effect. Patients who start taking sodium cromoglicate drops at the height of the grass pollen season in June will not achieve the same benefit as those who start in April. GPs prescribing or recommending mast cell stabilisers must explicitly advise patients to start before the season begins. Cold compresses are one of the most effective immediate interventions for allergic conjunctivitis itch and are entirely evidence-based — cold temperature reduces mast cell degranulation activity, constricts blood vessels (reducing conjunctival chemosis and hyperaemia), and provides a counter-irritation effect that overrides itch signalling. A cold flannel to closed eyes for 5 minutes can provide more rapid itch relief than any eye drop, costs nothing, and can be repeated multiple times daily. This should be taught to every patient with allergic conjunctivitis as first-line immediate management alongside pharmacological treatment.

The lid hygiene routine (warm compress → massage → lid scrub) sequence must be performed in this precise order because each step prepares for the next — the warm compress first softens the solidified meibum inside the meibomian glands (at 37°C it becomes more viscous and blocks the gland openings; warming to approximately 45°C liquefies it), the massage then expresses this liquid meibum from the glands onto the lid margin, and the scrub then removes the expressed meibum and debris before it reaccumulates. Performing the scrub without the warm compress first is much less effective because the glands are not primed for expression. The Eyebag (a microwavable wheat-filled bag designed specifically for warm lid compression) maintains temperature better than a wet flannel and can be a convenient option for patients. The doxycycline mechanism for blepharitis is primarily anti-inflammatory rather than antibiotic at the doses used — doxycycline at sub-antimicrobial doses (e.g. 40 mg modified-release once daily, or the older 20 mg twice-daily Periostat regimen) inhibits matrix metalloproteinases (MMPs) that are activated in the meibomian glands and conjunctiva in MGD and rosacea, causing local tissue inflammation and destruction of the lipid bilayer of the tear film. This MMP inhibition is independent of its antibiotic activity and explains why it works in posterior blepharitis where bacterial infection is not the primary mechanism. The 6–12 week course is typically needed before improvement is sustained, and courses may need to be repeated annually in chronic posterior blepharitis/rosacea. Preservative-free lubricants are significantly superior to preserved lubricants for chronic dry eye management — BAK preservative (present in most multidose lubricant eye drops) causes direct toxicity to corneal epithelial cells, goblet cells (which produce the mucin layer of the tear film), and meibomian gland cells with repeated use. In patients using lubricants more than 4 times daily, the BAK exposure becomes clinically significant and worsens the dry eye it is intended to treat. The NHS and RCOphth guidance is to use preservative-free lubricants when treatment frequency exceeds 4 times daily.

The keratoconus-eye rubbing link is one of the most important patient safety messages in allergic eye disease management — keratoconus (progressive corneal thinning and ectasia causing irregular astigmatism and visual distortion) is strongly associated with chronic vigorous eye rubbing, particularly in patients with VKC and atopic eye disease. The mechanical stress of rubbing causes corneal cell apoptosis, activation of corneal proteases (collagenases that break down the stromal collagen lamellae), and localised thinning that produces the characteristic conical corneal protrusion. Keratoconus is uncommon in the general population but has a higher prevalence in patients with atopic eye disease and chronic eye rubbing. It typically becomes clinically significant in the teens and 20s and can require corneal cross-linking (to halt progression) or corneal transplantation in advanced cases. Advising patients (especially children and adolescents with VKC) that eye rubbing must be avoided is a sight-preserving intervention. Pet-allergen interventions such as specialist cat foods have limited evidence and are optional, not essential treatment — give practical, proportionate trigger-avoidance advice.

The topical steroid monitoring imperative is one of the most important safety issues in primary care ophthalmology — a substantial proportion of people have a steroid responder phenotype that causes a significant rise in intraocular pressure (IOP) in response to topical ophthalmic corticosteroids. In steroid responders, IOP typically rises within 4–6 weeks of starting topical steroids and returns to normal after discontinuation. However, if sustained elevations are undetected and the steroid is continued, glaucomatous optic nerve damage can occur (steroid-induced open-angle glaucoma). GPs who receive a prescription for topical loteprednol, prednisolone acetate, or betamethasone eye drops from an ophthalmologist should: (1) ensure IOP was measured at the ophthalmology visit before prescription; (2) schedule an IOP check at 4–6 weeks with the community optometrist (most optometrists can measure IOP with non-contact tonometry); (3) not renew topical steroid prescriptions for eye conditions without ophthalmology review. The "treatment failure = reconsider diagnosis" principle for allergic conjunctivitis is practically important — many patients who do not respond to antihistamine drops and oral antihistamines have been treated for the wrong diagnosis. The three most commonly missed alternative diagnoses are: (1) dry eye masquerading as allergy (itch without watery discharge, worse with screen use, worse in the afternoon, BAK sensitivity from previous drops); (2) contact dermatoconjunctivitis from cosmetics or drop preservatives (worsens with continued use of the allergen-containing product); (3) chlamydial conjunctivitis (unilateral, follicular, sexually active, often accompanied by discharge that is not clearly purulent). Reviewing these three diagnoses at the "4 weeks not responding" review point, and examining the upper lid (eversion), testing VA, and taking a sexual history if appropriate, will identify the missed diagnosis in most cases.